The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.
Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.
By Product Type
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- MicroRNA Modification
- Large Non-coding RNA
- Chromatin Structures
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Adoption of Advanced Technologies Renders North America Dominant
From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region. In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.
Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.
The market in Asia Pacific is likely to witness strong growth during the forecast years. The primary factor responsible for the growth is developing healthcare infrastructure. The awareness about genomic technologies is increasing in countries such as India and China, as people in these countries are becoming more aware with regards to the detection of genetic disorders, their treatment and prognosis. All these factors are enabling growth in the market.
Some major points from Table of Content:
4.1GenomicsResearch Spending – For Key Countries, 2018
4.2RegulatoryScenario – For Key Countries
4.3Overview ofGenomics Service Provider
4.5Start-upswith their Funding Overview
4.5Key IndustryDevelopments – Mergers, Acquisitions and Partnerships
5.Global Genomics Market Analysis,Insights and Forecast, 2015-2026
5.1.KeyFindings / Summary
5.2.MarketAnalysis, Insights and Forecast – By Type
5.3.MarketAnalysis, Insights and Forecast – By Technology
5.3.1PolymeraseChain Reaction (PCR)
5.4.MarketAnalysis, Insights and Forecast – By Application
5.5.MarketAnalysis, Insights and Forecast – By End User
5.5.2HealthcareFacilities & Diagnostic Centers
5.5.3Pharmaceutical& Biotechnological Companies
5.5.4ContractResearch Organization (CROs)
5.6.MarketAnalysis, Insights and Forecast – By Region
5.6.5MiddleEast & Africa